122 related articles for article (PubMed ID: 37149904)
1. Adjuvant radiation therapy in early-stage endometrial cancer with abnormal beta-catenin expression is associated with improved local control.
Hui C; Mendoza MG; Snyder J; Dorigo O; Litkouhi B; Renz M; Karam A; Devereaux K; Howitt BE; Kidd EA
Gynecol Oncol; 2023 Jul; 174():42-48. PubMed ID: 37149904
[TBL] [Abstract][Full Text] [Related]
2. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
Ly D; Rowley BD; Dodson MK; Soisson PA; Jolles CJ; Gaffney DK; Sause WT
Gynecol Oncol; 2014 May; 133(2):250-5. PubMed ID: 24589416
[TBL] [Abstract][Full Text] [Related]
4. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
[TBL] [Abstract][Full Text] [Related]
5. Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
Francis SR; Ager BJ; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
Gynecol Oncol; 2019 Jul; 154(1):38-44. PubMed ID: 31029507
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of recurrence in early-stage endometrial carcinoma after delays in adjuvant radiation treatment.
Zhu S; Khalil R; Altairy O; Burmeister C; Dimitrova I; Elshaikh M
Int J Gynecol Cancer; 2021 Jan; 31(1):73-77. PubMed ID: 33087415
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer.
Yerramilli D; Chen YH; Venkatachalam V; Alban GM; Buscariollo DL; Cheng T; King MT; Pretz JL; Russo AL; Lee LJ
Pract Radiat Oncol; 2021; 11(5):394-403. PubMed ID: 34015544
[TBL] [Abstract][Full Text] [Related]
8. Aberrant nuclear β-catenin distribution does not prognosticate recurrences of endometrioid endometrial cancers - A retrospective single-institutional study.
Beshar I; Moon AS; Darji H; Liu C; Jennings MT; Dorigo O; Litkouhi B; Diver EJ; Karam AK; Howitt BE; Renz M
Gynecol Oncol; 2023 Dec; 179():85-90. PubMed ID: 37944330
[TBL] [Abstract][Full Text] [Related]
9. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?
Ager BJ; Francis SR; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
Brachytherapy; 2019; 18(4):453-461. PubMed ID: 31005603
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
[TBL] [Abstract][Full Text] [Related]
12. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
[TBL] [Abstract][Full Text] [Related]
13. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
Hathout L; Wang Y; Wang Q; Vergalasova I; Elshaikh MA; Dimitrova I; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Donovan E; Taunk NK; Chino J; Natesan D; Russo AL; Lea JS; Albuquerque KV; Lee LJ
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1423-1431. PubMed ID: 33677053
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003916. PubMed ID: 22513918
[TBL] [Abstract][Full Text] [Related]
16. A comparison of disease recurrence between robotic versus laparotomy approach in patients with intermediate-risk endometrial cancer.
Song J; Le T; Hopkins L; Fung-Kee-Fung M; Lupe K; Gaudet M; E C; Samant R
Int J Gynecol Cancer; 2020 Feb; 30(2):160-166. PubMed ID: 31871112
[TBL] [Abstract][Full Text] [Related]
17. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.
Mehta N; Yamada SD; Rotmensch J; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1004-9. PubMed ID: 14575831
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study).
Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Sostegni B; Bellicini A; Fuso L; Cristofani R; Sartori E
Gynecol Oncol; 2014 Jul; 134(1):29-35. PubMed ID: 24769176
[TBL] [Abstract][Full Text] [Related]
19. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
[TBL] [Abstract][Full Text] [Related]
20. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]